{"id":1876,"date":"2018-05-21T06:55:49","date_gmt":"2018-05-21T04:55:49","guid":{"rendered":"http:\/\/localhost\/fedecame\/?page_id=1876"},"modified":"2020-03-02T18:12:14","modified_gmt":"2020-03-02T17:12:14","slug":"cdr-asrames-nord-kivu","status":"publish","type":"page","link":"https:\/\/www.fedecame.net\/wp1\/?page_id=1876","title":{"rendered":"CDR ASRAMES \u2013 GOMA \/ Province du Nord KIVU"},"content":{"rendered":"<h5><strong>1.Identification de la CDR<\/strong><\/h5>\n<table style=\"height: 664px;\" width=\"1061\">\n<tbody>\n<tr>\n<td width=\"38\"><strong>N\u00b0<\/strong><\/td>\n<td width=\"284\"><strong>DESIGNATION<\/strong><\/td>\n<td width=\"189\"><\/td>\n<td width=\"227\"><strong>OBSERVATIONS<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>1<\/strong><\/td>\n<td width=\"284\"><strong>DATE DE CREATION<\/strong><\/td>\n<td width=\"189\"><strong>11 septembre 1993<\/strong><\/td>\n<td width=\"227\"><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>2<\/strong><\/td>\n<td width=\"284\"><strong>DATE D\u2019ACQUISITION DE LA PERSONNALITE JURIDIQUE<\/strong><\/td>\n<td width=\"189\"><strong>24 septembre 2007<\/strong><\/td>\n<td width=\"227\"><strong>Arr\u00eat\u00e9 minist\u00e9riel n\u00b0 0219\/CAB\/MIN\/J\/2007 du 24\/09\/2007<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>3<\/strong><\/td>\n<td width=\"284\"><strong>DATE D\u2019AUTORISATION D\u2019OUVERTURE EN TANT QUE ETABLISSEMENT PHARMACEUTIQUE<\/strong><\/td>\n<td width=\"189\"><strong>08 ao\u00fbt 2006<\/strong><\/td>\n<td width=\"227\"><strong>N\u00b0 1253\/20\/029\/2006<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>4<\/strong><\/td>\n<td width=\"284\"><strong>DATE DE SIGNATURE CONVENTION ETAT CDR<\/strong><\/td>\n<td width=\"189\"><strong>03 mars 2005<\/strong><\/td>\n<td width=\"227\"><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>5<\/strong><\/td>\n<td width=\"284\"><strong>DATE D\u2019ADOPTION DES STATUTS D\u2019ASBL<\/strong><\/td>\n<td width=\"189\"><strong>11 septembre 1993<\/strong><\/td>\n<td width=\"227\"><strong>Les premiers statuts de l\u2019asbl<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>6<\/strong><\/td>\n<td width=\"284\"><strong>DATE SIGNATURE CONVENTION CDR \u2013 FEDECAME<\/strong><\/td>\n<td width=\"189\"><\/td>\n<td width=\"227\"><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>7<\/strong><\/td>\n<td width=\"284\"><strong>POPULATION DESSERVIE<\/strong><\/td>\n<td width=\"189\"><strong>8.413.412 habitants <\/strong><\/td>\n<td width=\"227\"><strong>Fin 2016<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>8<\/strong><\/td>\n<td width=\"284\"><strong>NOMBRE DE ZONE DE SANTE COUVERTES<\/strong><\/td>\n<td width=\"189\"><strong>34<\/strong><\/td>\n<td width=\"227\"><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>9<\/strong><\/td>\n<td width=\"284\"><strong>NOMBRE DE ZONE DE SANTE SERVIES EFFECTIVEMENT<\/strong><\/td>\n<td width=\"189\"><strong>33<\/strong><\/td>\n<td width=\"227\"><strong>Une zone de sant\u00e9 n\u2019est pas encore op\u00e9rationnelle<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>10<\/strong><\/td>\n<td width=\"284\"><strong>EFFECTIF DU PERSONNEL<\/strong><\/td>\n<td width=\"189\"><strong>43<\/strong><\/td>\n<td width=\"227\"><strong>Sous traitance de manutention<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"38\"><strong>11<\/strong><\/td>\n<td width=\"284\"><strong>ADRESSE PHYSIQUE<\/strong><\/td>\n<td colspan=\"2\" width=\"416\"><strong>AVENUE DE MESANGES, N\u00b0 001, COMMUNE DE GOMA, VILLE DE GOMA, PROVINCE DU NORD-KIVU<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h5>2.Activit\u00e9s : bilan 2015 \u00e0 2017 &amp; pr\u00e9visions 2018<\/h5>\n<h6><strong>EVOLUTION DES CHIFFRES D\u2019AFFAIRES TROIS DERNIERES ANNEES<\/strong><\/h6>\n<p>(Vente Meg et Services en USD)<\/p>\n<table style=\"height: 160px;\" width=\"1020\">\n<tbody>\n<tr>\n<td width=\"85\"><strong>Ann\u00e9e<\/strong><\/td>\n<td width=\"132\"><strong>Chiffre d&rsquo;affaires Total<\/strong><\/td>\n<td width=\"132\"><strong>C.A. Ventes MEG<\/strong><\/td>\n<td width=\"132\"><strong>C.A. Ventes Services<\/strong><\/td>\n<td width=\"161\"><strong>Ventes Autres (\u00e9quipement solaires)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"85\"><strong>2015<\/strong><\/td>\n<td width=\"132\"><strong>5 393 791<\/strong><\/td>\n<td width=\"132\"><strong>4 260 236<\/strong><\/td>\n<td width=\"132\"><strong>929 081<\/strong><\/td>\n<td width=\"161\"><strong>204 475<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"85\"><strong>2016<\/strong><\/td>\n<td width=\"132\"><strong>6 436 273<\/strong><\/td>\n<td width=\"132\"><strong>4 638 041<\/strong><\/td>\n<td width=\"132\"><strong>1 645 877<\/strong><\/td>\n<td width=\"161\"><strong>152 355<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"85\"><strong>2017<\/strong><\/td>\n<td width=\"132\"><strong>7 844 198<\/strong><\/td>\n<td width=\"132\"><strong>5 817 519<\/strong><\/td>\n<td width=\"132\"><strong>1 876 131<\/strong><\/td>\n<td width=\"161\"><strong>150 548<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"85\"><strong>2018 (mi)<\/strong><\/td>\n<td width=\"132\"><strong>3 898 257<\/strong><\/td>\n<td width=\"132\"><strong>2 813 443<\/strong><\/td>\n<td width=\"132\"><strong>1 022 731<\/strong><\/td>\n<td width=\"161\"><strong>62 083<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h6><strong>VENTILATION DES VENTES DES MEDICAMENTS PAR GROUPES DES CLIENTS\u00a0 <\/strong><\/h6>\n<table style=\"height: 199px;\" width=\"1026\">\n<tbody>\n<tr>\n<td width=\"123\"><strong>Structure<\/strong><\/td>\n<td colspan=\"2\" width=\"139\"><strong>2015<\/strong><\/td>\n<td colspan=\"2\" width=\"135\"><strong>2016<\/strong><\/td>\n<td colspan=\"2\" width=\"104\"><strong>2017<\/strong><\/td>\n<td colspan=\"2\" width=\"142\"><strong>2018 (mi)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>\u00a0<\/strong><\/td>\n<td width=\"76\"><strong>Valeur\/usd<\/strong><\/td>\n<td width=\"64\"><strong>Ratio<\/strong><\/td>\n<td width=\"70\"><strong>Valeur\/usd<\/strong><\/td>\n<td width=\"65\"><strong>Ratio<\/strong><\/td>\n<td width=\"66\"><strong>Valeur\/usd<\/strong><\/td>\n<td width=\"38\"><strong>Ratio<\/strong><\/td>\n<td width=\"76\"><strong>Valeur\/usd<\/strong><\/td>\n<td width=\"66\"><strong>Ratio<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>CDR<\/strong><\/td>\n<td width=\"76\"><strong>379 754<\/strong><\/td>\n<td width=\"64\"><strong>7%<\/strong><\/td>\n<td width=\"70\"><strong>1 181 572<\/strong><\/td>\n<td width=\"65\"><strong>18%<\/strong><\/td>\n<td width=\"66\"><strong>2 023 110<\/strong><\/td>\n<td width=\"38\"><strong>26%<\/strong><\/td>\n<td width=\"76\"><strong>528 760<\/strong><\/td>\n<td width=\"66\"><strong>13%<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>HGR<\/strong><\/td>\n<td width=\"76\"><strong>159 972<\/strong><\/td>\n<td width=\"64\"><strong>3%<\/strong><\/td>\n<td width=\"70\"><strong>262 558<\/strong><\/td>\n<td width=\"65\"><strong>4%<\/strong><\/td>\n<td width=\"66\"><strong>246 064<\/strong><\/td>\n<td width=\"38\"><strong>3%<\/strong><\/td>\n<td width=\"76\"><strong>118 607<\/strong><\/td>\n<td width=\"66\"><strong>3%<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>ZS<\/strong><\/td>\n<td width=\"76\"><strong>1 183 519<\/strong><\/td>\n<td width=\"64\"><strong>22%<\/strong><\/td>\n<td width=\"70\"><strong>771 103<\/strong><\/td>\n<td width=\"65\"><strong>12%<\/strong><\/td>\n<td width=\"66\"><strong>1 301 875<\/strong><\/td>\n<td width=\"38\"><strong>17%<\/strong><\/td>\n<td width=\"76\"><strong>653 290<\/strong><\/td>\n<td width=\"66\"><strong>17%<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>ONG\/Agences\/Etat<\/strong><\/td>\n<td width=\"76\"><strong>3 670 547<\/strong><\/td>\n<td width=\"64\"><strong>68%<\/strong><\/td>\n<td width=\"70\"><strong>4 221 041<\/strong><\/td>\n<td width=\"65\"><strong>66%<\/strong><\/td>\n<td width=\"66\"><strong>4 273 149<\/strong><\/td>\n<td width=\"38\"><strong>54%<\/strong><\/td>\n<td width=\"76\"><strong>2 597 601<\/strong><\/td>\n<td width=\"66\"><strong>67%<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"123\"><strong>Total<\/strong><\/td>\n<td width=\"76\"><strong>5 393 791<\/strong><\/td>\n<td width=\"64\"><strong>100%<\/strong><\/td>\n<td width=\"70\"><strong>6 436 273<\/strong><\/td>\n<td width=\"65\"><strong>100%<\/strong><\/td>\n<td width=\"66\"><strong>7 844 198<\/strong><\/td>\n<td width=\"38\"><strong>100%<\/strong><\/td>\n<td width=\"76\"><strong>3 898 257<\/strong><\/td>\n<td width=\"66\"><strong>100%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>\u00a0<\/strong><\/p>\n<h6><strong>EVOLUTION DU FONDS DE ROULEMENT<\/strong><\/h6>\n<table width=\"634\">\n<tbody>\n<tr>\n<td width=\"227\"><strong>Indicateur<\/strong><\/td>\n<td width=\"105\"><strong>2015<\/strong><\/td>\n<td width=\"105\"><strong>2016<\/strong><\/td>\n<td width=\"93\"><strong>2017<\/strong><\/td>\n<td width=\"105\"><strong>\u00a0<\/strong><\/p>\n<p><strong>2018 (mi)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"227\"><strong>Fonds de Roulement en Usd<\/strong><\/td>\n<td width=\"105\"><strong>5 968 444<\/strong><\/td>\n<td width=\"105\"><strong>5 280 221<\/strong><\/td>\n<td width=\"93\"><strong>6 241 671<\/strong><\/td>\n<td width=\"105\"><strong>5\u00a0309 990<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h6><strong>VOLUMES DES ACHATS EFFECTUES AU COURS DE TROIS DERNIERES ANNEES PAR SOURCES (RESEAU ET HORS RESEAU)<\/strong><\/h6>\n<table width=\"637\">\n<tbody>\n<tr>\n<td colspan=\"2\" width=\"159\"><strong>2015<\/strong><\/td>\n<td colspan=\"2\" width=\"159\"><strong>2016<\/strong><\/td>\n<td colspan=\"2\" width=\"159\"><strong>2017<\/strong><\/td>\n<td colspan=\"2\" width=\"159\"><strong>2018 (mi)<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"80\"><strong>BCAF<\/strong><\/td>\n<td width=\"80\"><strong>Hors BCAF<\/strong><\/td>\n<td width=\"80\"><strong>BCAF<\/strong><\/td>\n<td width=\"80\"><strong>Hors BCAF<\/strong><\/td>\n<td width=\"80\"><strong>BCAF<\/strong><\/td>\n<td width=\"80\"><strong>Hors BCAF<\/strong><\/td>\n<td width=\"80\"><strong>BCAF<\/strong><\/td>\n<td width=\"80\"><strong>Hors BCAF<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"80\"><strong>3 508 152<\/strong><\/td>\n<td width=\"80\"><strong>0<\/strong><\/td>\n<td width=\"80\"><strong>3 754 864<\/strong><\/td>\n<td width=\"80\"><strong>0<\/strong><\/td>\n<td width=\"80\"><strong>3 773 146<\/strong><\/td>\n<td width=\"80\"><strong>0<\/strong><\/td>\n<td width=\"80\"><strong>1 777 310<\/strong><\/td>\n<td width=\"80\"><strong>0<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h6><strong>RECEPTIONS VENTILEES PAR ANNEE DE PASSATION DES COMMANDES (EN USD)<\/strong><\/h6>\n<table style=\"height: 296px;\" width=\"766\">\n<tbody>\n<tr>\n<td width=\"198\">Fournisseurs<\/td>\n<td width=\"116\">2 014<\/td>\n<td width=\"151\">2 015<\/td>\n<td width=\"99\">2 016<\/td>\n<td width=\"102\">Total en USD<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">AVICENNA LIMITED<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">61 208,74<\/td>\n<td width=\"99\">265 233,86<\/td>\n<td width=\"102\">326 442,60<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">IDA FOUNDATION<\/td>\n<td width=\"116\">15 691,28<\/td>\n<td width=\"151\">470 141,33<\/td>\n<td width=\"99\">108 169,96<\/td>\n<td width=\"102\">594 002,57<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">IMRES B.V.<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">16 848,71<\/td>\n<td width=\"99\">&#8211;<\/td>\n<td width=\"102\">16 848,71<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">MEG<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">289 693,83<\/td>\n<td width=\"99\">288 834,00<\/td>\n<td width=\"102\">578 527,83<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">MISSION PHARMA<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">431 938,60<\/td>\n<td width=\"99\">515 267,71<\/td>\n<td width=\"102\">947 206,31<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">PHARMAKINA Sarl<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">0,00<\/td>\n<td width=\"99\">122 948,06<\/td>\n<td width=\"102\">122 948,06<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">SVIZERA EUROPE BV<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">25 786,77<\/td>\n<td width=\"99\">277109,26<\/td>\n<td width=\"102\">302 896,03<\/td>\n<\/tr>\n<tr>\n<td width=\"198\">AUTRES (WASSOLU KUBOTA)<\/td>\n<td width=\"116\">&#8211;<\/td>\n<td width=\"151\">&#8211;<\/td>\n<td width=\"99\">29 620,48<\/td>\n<td width=\"102\">29 620,48<\/td>\n<\/tr>\n<tr>\n<td width=\"198\"><strong>Total en USD <\/strong><\/td>\n<td width=\"116\"><strong>15 691,28 <\/strong><\/td>\n<td width=\"151\"><strong>1 295 617,98 <\/strong><\/td>\n<td width=\"99\"><strong>1 607 183,33 <\/strong><\/td>\n<td width=\"102\"><strong>2 918 492,59 <\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h5><strong>3. Contacts\u00a0: <\/strong><\/h5>\n<p>Courriel\u00a0: <a href=\"mailto:info@asrames.org\">info@asrames.org<\/a><\/p>\n<p><strong>Directeur\u00a0Gaston NYAMAMBICHI <\/strong><\/p>\n<p>T\u00e9l\u00e9phone\u00a0: 0998088169<\/p>\n<p>Courriel\u00a0:<a href=\"mailto:dir@asrames.org\">dir@asrames.org<\/a><\/p>\n<p><strong>Directeur Adjoint\u00a0 Arthur KATAVALI<br \/>\n<\/strong><\/p>\n<p>T\u00e9l\u00e9phone\u00a0: 099860497<\/p>\n<p>Courriel\u00a0: <a href=\"mailto:depha1@asrames.org\">depha1@asrames.org<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>1.Identification de la CDR N\u00b0 DESIGNATION OBSERVATIONS 1 DATE DE CREATION 11 septembre 1993 2 DATE D\u2019ACQUISITION DE LA PERSONNALITE JURIDIQUE 24 septembre 2007 Arr\u00eat\u00e9 minist\u00e9riel n\u00b0 0219\/CAB\/MIN\/J\/2007 du 24\/09\/2007 3 DATE D\u2019AUTORISATION D\u2019OUVERTURE EN TANT QUE ETABLISSEMENT PHARMACEUTIQUE 08 ao\u00fbt 2006 N\u00b0 1253\/20\/029\/2006 4 DATE DE SIGNATURE CONVENTION ETAT CDR 03 mars 2005 5&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/pages\/1876"}],"collection":[{"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1876"}],"version-history":[{"count":10,"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/pages\/1876\/revisions"}],"predecessor-version":[{"id":2506,"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=\/wp\/v2\/pages\/1876\/revisions\/2506"}],"wp:attachment":[{"href":"https:\/\/www.fedecame.net\/wp1\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}